• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC TAG THORACIC ENDOPROSTHESIS (CTAG); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC TAG THORACIC ENDOPROSTHESIS (CTAG); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number TGU373710J
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Air Embolism (1697); Infarction, Cerebral (1771)
Event Date 01/11/2020
Event Type  Injury  
Manufacturer Narrative
Per the gore® tag® conformable thoracic stent graft with active control system instructions for use, adverse events that may occur and/or require intervention include, but are not limited to, neurologic damage.See also mfg report# 2017233-2020-00099.
 
Event Description
On (b)(6) 2020, a patient underwent a treatment of thoracic aortic aneurysm with conformable gore® tag® thoracic endoprostheses.After an ax-ax bypass was performed, tgu454515 was placed under the lcca.Then an embolization of the origin of the lsa using coil and plug was performed.Although the procedure was completed without any problem, the patient did not recover from anesthesia.A stroke was suspected and an mri was conducted.The mri revealed a cerebral infarction.The physician suspected a thromboembolism, and an unknown medication was administered.On (b)(6) 2020, the patient was reported to still be unconscious, but was in the icu and breathing spontaneously.The physician now suspects an air embolism.No additional intervention is planned.
 
Manufacturer Narrative
Method code - code 3331 added for results of manufacturing evaluation code 213 - the review of the manufacturing paperwork verified that this lot met all pre-release specifications code 22 ¿ according to the gore® tag® conformable thoracic stent graft with active control system instructions for use, adverse events that may occur and/or require intervention include, but are not limited to, neurologic damage.See also mfg report# 2017233-2020-00099.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC TAG THORACIC ENDOPROSTHESIS (CTAG)
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key9716736
MDR Text Key179627409
Report Number2017233-2020-00100
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P040043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 03/06/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/09/2021
Device Catalogue NumberTGU373710J
Device Lot Number20417133
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received02/17/2020
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received03/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age85 YR
-
-